Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 3/20 | 0.45 |
| ▸ | CTSH | P09668 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450698 | 1.00 | TDP1 (0.50) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL1804954 | 1.00 | TDP1 (0.50) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| 1-Nitropyrene SCHEMBL29450697 | 0.92 | ALDH1A1 (0.57) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| 1-Nitropyrene SCHEMBL339725 | 0.92 | ALDH1A1 (0.57) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL29403406 | 0.92 | HPRT1 (0.49) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL16593674 | 0.92 | HPRT1 (0.49) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| 1-Nitropyrene SCHEMBL28378090 | 0.90 | ALDH1A1 (0.55) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL16593473 | 0.88 | TDP1 (0.44) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL4539666 | 0.88 | CTSB (0.59) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL14298072 | 0.88 | ALDH1A1 (0.42) | TDP1ALDH1A1CYP3A4ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025124901-A1 | PROCESS FOR PRODUCING PURIFIED CARBON BLACKS WITH REDUCED CONTENT OF OXIDIZED POLYCYCLIC AROMATIC HYDROCARBONS | ORION ENGINEERED CARBONS IP GMBH & CO. KG (DE) | 2025-06-19 | — | — | WO | claimed |
| CN-114686215-B | Fluorescent material and preparation method and application thereof | TCL科技集团股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-114686215-A | Fluorescent material and preparation method and application thereof | TCL科技集团股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113960220-B | Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood | 生态环境部华南环境科学研究所 | 2022-03-04 | — | — | CN | claimed |
| CN-113960220-A | Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood | 生态环境部华南环境科学研究所 | 2022-01-21 | — | — | CN | claimed |
| US-10808142-B2 | Method of preparing graphene quantum dot, hardmask composition including the graphene quantum dot obtained by the method, method of forming patterns using the hardmask composition, and hardmask formed from the hardmask composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-10-20 | — | — | US | claimed |
| US-20190031906-A1 | METHOD OF PREPARING GRAPHENE QUANTUM DOT, HARDMASK COMPOSITION INCLUDING THE GRAPHENE QUANTUM DOT OBTAINED BY THE METHOD, METHOD OF FORMING PATTERN USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED FROM THE HARDMASK COMPOSITION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-01-31 | — | — | US | claimed |
| US-20110015149-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS | CHIMERIX, INC. | 2011-01-20 | — | — | US | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| CN-121674302-B | Lactobacillus plantarum, zhong Huang ferment, preparation method and application thereof in improving bone health | Hunan Nutrition Tree Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4263724-B1 | PROCESS FOR PRODUCING CARBON BLACKS WITH REDUCED POLYCYCLIC AROMATIC HYDROCARBON CONTENT UTILIZING SUPERCRITICAL FLUID EXTRACTION | ORION ENG CARBONS IP GMBH & CO KG (DE) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025124901-A1 | PROCESS FOR PRODUCING PURIFIED CARBON BLACKS WITH REDUCED CONTENT OF OXIDIZED POLYCYCLIC AROMATIC HYDROCARBONS | ORION ENGINEERED CARBONS IP GMBH & CO. KG (DE) | 2025-06-19 | — | — | WO | disclosed |
| CN-116072855-B | Silicon-carbon negative electrode material and preparation method thereof | 中国科学院成都有机化学有限公司 | 2025-06-17 | — | — | CN | disclosed |
| WO-2002037990-A2 | METHOD AND PRODUCT FOR REMOVING CARCINOGENS FROM TOBACCO SMOKE | VECTOR TOBACCO LTD. (BM) | 2002-05-16 | — | — | WO | disclosed |
| EP-0742722-B1 | METHOD FOR INCREASING BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOSITIONS | UNIV CALIFORNIA (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001097843-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-1127579-A2 | Method for increasing bioavailability of oral pharmaceutical compositions | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000003721-A1 | IMMUNOSUPPORTIVE DRUG SPARING DIET | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2000-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015149-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS | ACE, CYP27A1, LIPC | TDP1 1517/4885ALDH1A1 857/4885CYP3A4 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.